has been awarded almost $7.5 million to accelerate improvements in the prevention, diagnosis, treatment and management of dementia.
Â鶹´«Ã½Ó³» received the largest allocation of any university in the 2017 round of (NHMRC) grants to boost dementia research.
Deputy Vice-Chancellor (Research) said Â鶹´«Ã½Ó³» would undertake seven dementia initiatives in an effort to improve outcomes for patients, their families and communities.
“Dementia is Australia’s second leading cause of death and we are scaling up our efforts in line with this global health priority,” Professor Ward said.
“The number of deaths caused by dementia is growing, and with our ageing population there are significant implications across society.
“Projects funded at Â鶹´«Ã½Ó³» address a broad cross-section of the many challenges arising from this life-changing group of diseases.
“Importantly, our three major grants will result in the implementation of research into clinical practice and care.”
A $1.87 million project led by from Â鶹´«Ã½Ó³»’s Faculty of Medicine will address the urgent need for interventions to manage driving cessation, to support patients, their families and GPs.
from the Centre for Health Services Research (CHSR), Faculty of Medicine will use a $1.86 million grant to develop an electronic nursing assessment system, and Quality of Care Benchmarking Consortium, to improve detection of dementia when patients are admitted to hospitals.
A $1.06 million project led by from the School of Health and Rehabilitation Sciences, Faculty of Health and Behavioural Sciences, will investigate the implementation of a program delivered by occupational therapists to provide individually tailored training and support for people with dementia and their carers living at home in the community.
Four dementia research leadership Fellowships were awarded to Â鶹´«Ã½Ó³».
Innovative neurocognitive methods to achieve earlier diagnosis and develop tailored interventions to maintain function will be the focus of the School of Psychology’s Associate Professor Gail Robinson.
from Queensland Brain Institute (QBI) will investigate biological pathways in the onset and progression of Alzheimer’s disease, to identify potential biomarkers and therapeutic targets.
At the Faculty of Medicine’s Centre for Clinical Research, will develop an integrated network to maximise treatment outcomes for depression and anxiety in people with dementia.
Associate Professor Tracy Comans from will develop ways to measure the cost-effectiveness of treatments and dementia care packages, to ensure resources are directed into programs most likely to be of benefit.
Media: Kim Lyell, k.lyell@uq.edu.au, 0427 530647.
